Cargando…

Histological study on the protective effect of endogenous stem-cell mobilization in Adriamycin-induced chronic nephropathy in rats

Chronic kidney disease is a global health problem with increasing morbidity and mortality. Therefore, this study was planned to test the protective effect of hematopoietic-stem-cell mobilization by granulocyte colony-stimulating factor (G-CSF) on Adriamycin (ADR)-induced chronic renal disease in rat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sadek, Eman Mostafa, Salama, Nagla Mohamed, Ismail, Dalia Ibrahim, Elshafei, Asmaa Ahmed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6014195/ https://www.ncbi.nlm.nih.gov/pubmed/30023219 http://dx.doi.org/10.1016/j.jmau.2015.12.003

Ejemplares similares

Histological Study on the Protective Effect of Endogenous Stem Cell Mobilization in Busulfan-Induced Testicular Injury in Albino Rats
por: Aboul Fotouh, Gihan Ibrahim, et al.
Publicado: (2018)

Mesenchymal Stem Cells Ameliorate Renal Inflammation in Adriamycin-induced Nephropathy
por: Kim, Hyung Sook, et al.
Publicado: (2019)

Effects of Pravastatin in Adriamycin-Induced Nephropathy in Rats
por: Mansouri, Esrafil, et al.
Publicado: (2018)

Simvastatin ameliorates glomerulosclerosis in Adriamycin-induced-nephropathy rats
por: Zhang, Wei, et al.
Publicado: (2008)

Measures of kidney function by minimally invasive techniques correlate with histological glomerular damage in SCID mice with adriamycin-induced nephropathy
por: Scarfe, Lauren, et al.
Publicado: (2015)

Human induced pluripotent stem cell-derived mesenchymal stem cells prevent adriamycin nephropathy in mice
por: Wu, Hao Jia, et al.
Publicado: (2017)

Capsazepine (CPZ) Inhibits TRPC6 Conductance and Is Protective in Adriamycin-Induced Nephropathy and Diabetic Glomerulopathy
por: Hagmann, Henning, et al.
Publicado: (2023)

Endothelin Receptor A Blockade Is an Ineffective Treatment for Adriamycin Nephropathy
por: Tan, Roderick J., et al.
Publicado: (2013)

P2X7R antagonist protects against renal injury in mice with adriamycin nephropathy
por: Zhu, Yanji, et al.
Publicado: (2022)

Vincristine alleviates adriamycin-induced nephropathy through stabilizing actin cytoskeleton
por: Yin, Lei, et al.
Publicado: (2017)

Ameliorating Effect of Gemigliptin on Renal Injury in Murine Adriamycin-Induced Nephropathy
por: Kim, Da Rae, et al.
Publicado: (2017)

Salidroside ameliorates Adriamycin nephropathy in mice by inhibiting β‐catenin activity
por: Huang, Xinzhong, et al.
Publicado: (2019)

Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss
por: Dai, Rufeng, et al.
Publicado: (2019)

Protection against acute adriamycin-induced cardiotoxicity by garlic: Role of endogenous antioxidants and inhibition of TNF-α expression
por: Mukherjee, Sumanta, et al.
Publicado: (2003)

Acatalasemic mice are mildly susceptible to adriamycin nephropathy and exhibit increased albuminuria and glomerulosclerosis
por: Takiue, Keiichi, et al.
Publicado: (2012)

Glomerular Endothelial Cell Injury and Damage Precedes That of Podocytes in Adriamycin-Induced Nephropathy
por: Sun, Yu Bo Yang, et al.
Publicado: (2013)

Cobrotoxin from Naja naja atra Venom Ameliorates Adriamycin Nephropathy in Rats
por: Wang, Shu-Zhi, et al.
Publicado: (2015)

Huaier Cream Protects against Adriamycin-Induced Nephropathy by Restoring Mitochondrial Function via PGC-1α Upregulation
por: Che, Ruochen, et al.
Publicado: (2015)

Resolvin D1 Protects Podocytes in Adriamycin-Induced Nephropathy through Modulation of 14-3-3β Acetylation
por: Zhang, Xueming, et al.
Publicado: (2013)

M2c Macrophages Protect Mice from Adriamycin-Induced Nephropathy by Upregulating CD62L in Tregs
por: Lu, Junyu, et al.
Publicado: (2022)

Erratum to “Effect of Nephropathy Prescription I on the Expression of Angptl3 and Podocyte-Associated Protein in Mice with Adriamycin-Induced Nephropathy”
por: Zhang, Feifei, et al.
Publicado: (2023)

Treatment with irbesatan may improve slit diaphragm alterations in rats with adriamycin-induced nephropathy
por: Wang, Na, et al.
Publicado: (2016)

Effects of a Chinese herbal extract on the intestinal tract and aquaporin in Adriamycin-induced nephropathy
por: Ma, Weizhong, et al.
Publicado: (2022)

Genetic background strongly influences the transition to chronic kidney disease of adriamycin nephropathy in mice
por: Watanabe, Masaki, et al.
Publicado: (2022)

Protective effect of melatonin against Adriamycin-induced cardiotoxicity
por: ZHANG, YAN, et al.
Publicado: (2013)

Minnelide combined with anti-ANGPTL3-FLD monoclonal antibody completely protects mice with adriamycin nephropathy by promoting autophagy and inhibiting apoptosis
por: Ji, Baowei, et al.
Publicado: (2023)

Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia.
por: Tobias, J. S., et al.
Publicado: (1975)

Impact of Light/Dark Cycle Patterns on Oxidative Stress in an Adriamycin-Induced Nephropathy Model in Rats
por: Escribano, Begoña M., et al.
Publicado: (2014)

Osteocrin ameliorates adriamycin nephropathy via p38 mitogen-activated protein kinase inhibition
por: Handa, Takaya, et al.
Publicado: (2021)

Adriamycin-Induced Nephropathy is Robust in N and Modest in J Substrain of C57BL/6
por: Bryant, Claire, et al.
Publicado: (2022)

Protective effects and mechanisms of psoralidin against adriamycin-induced cardiotoxicity
por: Liang, Zhenxing, et al.
Publicado: (2021)

Correction: Impact of Light/Dark Cycle Patterns on Oxidative Stress in an Adriamycin-Induced Nephropathy Model in Rats
Publicado: (2014)

Inflammation Induces Lipid Deposition in Kidneys by Downregulating Renal PCSK9 in Mice with Adriamycin-Induced Nephropathy
por: Zhang, Gaofu, et al.
Publicado: (2019)

Yes-associated protein regulates podocyte cell cycle re-entry and dedifferentiation in adriamycin-induced nephropathy
por: Xie, Kewei, et al.
Publicado: (2019)

Artemether ameliorates kidney injury by restoring redox imbalance and improving mitochondrial function in Adriamycin nephropathy in mice
por: Han, Pengxun, et al.
Publicado: (2021)

Paricalcitol Improves the Angiopoietin/Tie-2 and VEGF/VEGFR2 Signaling Pathways in Adriamycin-Induced Nephropathy
por: Deluque, Amanda Lima, et al.
Publicado: (2022)

Inhibitors of adriamycin-induced histamine release in vitro limit adriamycin cardiotoxicity in vivo.
por: Klugmann, F. B., et al.
Publicado: (1986)

Beneficial Effects of the Activation of the Angiotensin-(1–7) Mas Receptor in a Murine Model of Adriamycin-Induced Nephropathy
por: Silveira, Kátia Daniela, et al.
Publicado: (2013)

Detection of Adriamycin–DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations
por: Coldwell, Kate E., et al.
Publicado: (2008)

The stem cell factor antibody enhances the chemotherapeutic effect of adriamycin on chemoresistant breast cancer cells
por: Jelly, Neil D, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_340o975b2depfuenem9mg42u1e